113 related articles for article (PubMed ID: 11544975)
1. AIDS in Africa--survival according to AIDS-defining illness.
Post FA; Badri M; Wood R; Maartens G
S Afr Med J; 2001 Jul; 91(7):583-6. PubMed ID: 11544975
[TBL] [Abstract][Full Text] [Related]
2. The role of initial AIDS-defining illness in survival following AIDS.
Luo K; Law M; Kaldor JM; McDonald AM; Cooper DA
AIDS; 1995 Jan; 9(1):57-63. PubMed ID: 7893442
[TBL] [Abstract][Full Text] [Related]
3. Impact of opportunistic disease on survival in patients with HIV infection.
Chaisson RE; Gallant JE; Keruly JC; Moore RD
AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252
[TBL] [Abstract][Full Text] [Related]
4. Survival after AIDS-defining events in patients with < 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial Group.
Pueyo S; Salmi LR; Chêne G; Leport C; Morlat P; Dequae L; Grégoire V; Hafner R; Vildé JL; Luft BJ; Aubertin J; Salamon R
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(5):459-64. PubMed ID: 9170421
[TBL] [Abstract][Full Text] [Related]
5. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.
Mocroft AJ; Lundgren JD; d'Armino Monforte A; Ledergerber B; Barton SE; Vella S; Katlama C; Gerstoft J; Pedersen C; Phillips AN
Int J Epidemiol; 1997 Apr; 26(2):400-7. PubMed ID: 9169177
[TBL] [Abstract][Full Text] [Related]
6. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival.
Colford JM; Tager IB; Hirozawa AM; Lemp GF; Aragon T; Petersen C
Am J Epidemiol; 1996 Nov; 144(9):807-16. PubMed ID: 8890659
[TBL] [Abstract][Full Text] [Related]
7. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
Grabar S; Lanoy E; Allavena C; Mary-Krause M; Bentata M; Fischer P; Mahamat A; Rabaud C; Costagliola D;
HIV Med; 2008 Apr; 9(4):246-56. PubMed ID: 18366449
[TBL] [Abstract][Full Text] [Related]
8. Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft AJ; Johnson MA; Sabin CA; Lipman M; Elford J; Emery V; Morcinek J; Youle M; Janossy G; Lee CA
Lancet; 1995 Jul; 346(8966):12-7. PubMed ID: 7603137
[TBL] [Abstract][Full Text] [Related]
9. Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic.
Martinez-Steele E; Awasana AA; Corrah T; Sabally S; van der Sande M; Jaye A; Togun T; Sarge-Njie R; McConkey SJ; Whittle H; Schim van der Loeff MF
AIDS; 2007 Jan; 21(3):317-24. PubMed ID: 17255738
[TBL] [Abstract][Full Text] [Related]
10. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
[TBL] [Abstract][Full Text] [Related]
11. Survival by AIDS defining condition in rural Uganda.
Morgan D; Malamba SS; Orem J; Mayanja B; Okongo M; Whitworth JA
Sex Transm Infect; 2000 Jun; 76(3):193-7. PubMed ID: 10961197
[TBL] [Abstract][Full Text] [Related]
12. Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011).
Kaplan R; Caldwell J; Middelkoop K; Bekker LG; Wood R
J Acquir Immune Defic Syndr; 2014 Aug; 66(5):487-94. PubMed ID: 24820105
[TBL] [Abstract][Full Text] [Related]
13. The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l.
Coakley EP; Samore MH; Gillis JM; Hughes MD; Hammer SM
AIDS; 2000 Jun; 14(9):1147-53. PubMed ID: 10894278
[TBL] [Abstract][Full Text] [Related]
14. Changing trends in clinical AIDS presentations and survival among HIV-1-infected women.
Charurat M; Blattner W; Hershow R; Buck A; Zorrilla CD; Watts DH; Paul M; Landesman S; Adeniyi-Jones S; Tuomala R;
J Womens Health (Larchmt); 2004; 13(6):719-30. PubMed ID: 15333287
[TBL] [Abstract][Full Text] [Related]
15. Independent epidemics of heterosexual and homosexual HIV infection in South Africa--survival differences.
Maartens G; Wood R; O'Keefe E; Byrne C
QJM; 1997 Jul; 90(7):449-54. PubMed ID: 9302428
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
[TBL] [Abstract][Full Text] [Related]
17. Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia.
Dore GJ; Li Y; McDonald A; Ree H; Kaldor JM;
J Acquir Immune Defic Syndr; 2002 Apr; 29(4):388-95. PubMed ID: 11917244
[TBL] [Abstract][Full Text] [Related]
18. Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014.
Tanuma J; Lee KH; Haneuse S; Matsumoto S; Nguyen DT; Nguyen DT; Do CD; Pham TT; Nguyen KV; Oka S
PLoS One; 2016; 11(3):e0150781. PubMed ID: 26939050
[TBL] [Abstract][Full Text] [Related]
19. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
; Mocroft A; Sterne JA; Egger M; May M; Grabar S; Furrer H; Sabin C; Fatkenheuer G; Justice A; Reiss P; d'Arminio Monforte A; Gill J; Hogg R; Bonnet F; Kitahata M; Staszewski S; Casabona J; Harris R; Saag M
Clin Infect Dis; 2009 Apr; 48(8):1138-51. PubMed ID: 19275498
[TBL] [Abstract][Full Text] [Related]
20. The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft A; Youle M; Phillips AN; Halai R; Easterbrook P; Johnson MA; Gazzard B
Arch Intern Med; 1998 Mar; 158(5):491-7. PubMed ID: 9508227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
